Dr. Rizwan Ahmed Dudekula, MD

Dr. Dudekula practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System.

Dr. Dudekula's NPI, 1619383718, was assigned on July 9, 2014. Dr. Dudekula holds New York license 301766.

Dr. Dudekula's primary practice is Ochsner Medical Center - New Orleans, at 1516 Jefferson Hwy, New Orleans, LA 70121 in Jefferson Parish. The practice phone is (504) 842-3000.

Dr. Dudekula's primary practice is Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System. The medical group on file is Ochsner Health. Dmand AI also links Dr. Dudekula to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dudekula practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Dudekula's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Dudekula is licensed in New York.

CMS data shows 754 Medicare services from Dr. Dudekula across 20 procedure codes in 2024, for 197 Medicare patients. Medicare paid $46,023 for them.

CMS counts 197 Medicare patients who saw Dr. Dudekula in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dudekula's median patient age at 73, with 52% women.

In 2024, Dr. Dudekula wrote 1,951 Medicare Part D claims for 203 patients. 69% of them were for generic drugs. CMS names the drug for 1,470 of them, across 42 drugs with 11 or more claims each, at $242,232 in total drug cost. In 2023, CMS named 1,878 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Dudekula for performance year 2024, reported as part of a group. Dr. Dudekula accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dudekula as offering telehealth.

Dmand AI links 5 papers to Dr. Dudekula, published from 2017 to 2020. 2017 was the busiest year, with 2. Dr. Dudekula's most frequent co-authors are Misbahuddin Khaja, MD, Sandeep K. Malik, MD and Umair Ashraf, MD.

CMS Open Payments shows 184 general payments to Dr. Dudekula from 24 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 96% of the total. GlaxoSmithKline, LLC. paid the most, $913.